173 related articles for article (PubMed ID: 7679459)
1. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen.
Kefalides NA; Ohno N; Wilson CB
Kidney Int; 1993 Jan; 43(1):85-93. PubMed ID: 7679459
[TBL] [Abstract][Full Text] [Related]
2. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome.
Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG
J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284
[TBL] [Abstract][Full Text] [Related]
3. Non-Goodpasture anti-GBM antibodies in patients with glomerulonephritis.
Bygren P; Cederholm B; Heinegård D; Wieslander J
Nephrol Dial Transplant; 1989; 4(4):254-61. PubMed ID: 2502732
[TBL] [Abstract][Full Text] [Related]
4. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis.
Kefalides NA; Pegg MT; Ohno N; Poon-King T; Zabriskie J; Fillit H
J Exp Med; 1986 Mar; 163(3):588-602. PubMed ID: 3950543
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the human Goodpasture antigen.
Wieslander J; Kataja M; Hudson BG
Clin Exp Immunol; 1987 Aug; 69(2):332-40. PubMed ID: 3652534
[TBL] [Abstract][Full Text] [Related]
7. Alveolar basement membrane: molecular properties of the noncollagenous domain (hexamer) of collagen IV and its reactivity with Goodpasture autoantibodies.
Gunwar S; Bejarano PA; Kalluri R; Langeveld JP; Wisdom BJ; Noelken ME; Hudson BG
Am J Respir Cell Mol Biol; 1991 Aug; 5(2):107-12. PubMed ID: 1892641
[TBL] [Abstract][Full Text] [Related]
8. Sera from patients with anti-GBM nephritis including goodpasture syndrome show heterogenous reactivity to recombinant NC1 domain of type IV collagen alpha chains.
Dehan P; Weber M; Zhang X; Reeders ST; Foidart JM; Tryggvason K
Nephrol Dial Transplant; 1996 Nov; 11(11):2215-22. PubMed ID: 8941581
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Goodpasture antigens within various human basement membranes.
Weber M; Pullig O; Köhler H
Nephrol Dial Transplant; 1990; 5(2):87-93. PubMed ID: 2113218
[TBL] [Abstract][Full Text] [Related]
10. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
[TBL] [Abstract][Full Text] [Related]
11. Identification of antigenic epitopes in type IV collagen by use of synthetic peptides.
Kefalides NA; Ohno N; Wilson CB; Fillit H; Zabriski J; Rosenbloom J
Kidney Int; 1993 Jan; 43(1):94-100. PubMed ID: 7679460
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
Thorner PS; Baumal R; Eddy A; Marrano P
Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
Hellmark T; Brunmark C; Trojnar J; Wieslander J
Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
[TBL] [Abstract][Full Text] [Related]
14. Antigen restriction and IgG subclasses among anti-GBM autoantibodies.
Segelmark M; Butkowski R; Wieslander J
Nephrol Dial Transplant; 1990; 5(12):991-6. PubMed ID: 2128958
[TBL] [Abstract][Full Text] [Related]
15. The Goodpasture antigen: common epitopes in the globular domains of collagen IV.
Matsukura H; Butkowski RJ; Fish AJ
Nephron; 1993; 64(4):532-9. PubMed ID: 7690113
[TBL] [Abstract][Full Text] [Related]
16. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
17. Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope.
Hellmark T; Segelmark M; Wieslander J
Nephrol Dial Transplant; 1997 Apr; 12(4):646-8. PubMed ID: 9140985
[No Abstract] [Full Text] [Related]
18. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
Kalluri R; Danoff TM; Okada H; Neilson EG
J Clin Invest; 1997 Nov; 100(9):2263-75. PubMed ID: 9410904
[TBL] [Abstract][Full Text] [Related]
19. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen.
Wieslander J; Barr JF; Butkowski RJ; Edwards SJ; Bygren P; Heinegård D; Hudson BG
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3838-42. PubMed ID: 6328527
[TBL] [Abstract][Full Text] [Related]
20. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
